Three FDA Decisions Loom After Summit’s Rejection — Capricor, Savara, Alzheimer’s Data Top Biotech’s Watchlist
Capricor and Savara face Nov.22 FDA deadlines, while Beren Therapeutics awaits a Tuesday decision on Adrabetadex.
Capricor and Savara face Nov.22 FDA deadlines, while Beren Therapeutics awaits a Tuesday decision on Adrabetadex.